Globally experienced pharmaceutical professional with successful leadership track record across early product development, commercial product launches and strategic asset valuation for Business Development, Licensing and M&A.

New product development achievements highlighted by close partnering with R&D and various BD functional areas.  Notable strengths in strategic brand planning and in fostering customer relationships.

A key deliverable for many organizations is the creation of an independent and validated commercial assessment for clinical stage assets.  Reliable assessments support reliable product valuations, inform strategic decision making and enable successful partnering often key to funding and advancing programs to market.